Sihuan Biotech announced that the company plans to apply for a merger and acquisition loan with a total amount of not more than 230 million yuan from the Wuxi branch of China Merchants Bank to pay part of the transaction amount for the acquisition of 65.6146% of Zhongrun Pharmaceutical's shares and 80% of Changyuan Pharmaceutical's shares. The loan amount, term, interest rate and collateral conditions are subject to the bank's approval and final signed loan agreement. The board of directors of the company has authorized management to handle matters relating to mergers and acquisitions loans within the above amounts, and there is no need to submit this matter to the shareholders' meeting for consideration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.